SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-001033
Filing Date
2010-02-19
Accepted
2010-02-19 17:27:39
Documents
16
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2196377z10-k.htm 10-K 1528341
2 EXHIBIT 10.33 a2196377zex-10_33.htm EX-10.33 23000
3 EXHIBIT 10.42 a2196377zex-10_42.htm EX-10.42 80927
4 EXHIBIT 10.43 a2196377zex-10_43.htm EX-10.43 54698
5 EXHIBIT 10.58 a2196377zex-10_58.htm EX-10.58 16747
6 EXHIBIT 10.59 a2196377zex-10_59.htm EX-10.59 12589
7 EXHIBIT 21.1 a2196377zex-21_1.htm EX-21.1 5903
8 EXHIBIT 23.1 a2196377zex-23_1.htm EX-23.1 4607
9 EXHIBIT 31.1 a2196377zex-31_1.htm EX-31.1 13948
10 EXHIBIT 31.2 a2196377zex-31_2.htm EX-31.2 13599
11 EXHIBIT 32.1 a2196377zex-32_1.htm EX-32.1 8867
12 G781575.JPG g781575.jpg GRAPHIC 44959
13 G676803.JPG g676803.jpg GRAPHIC 32473
14 G635866.JPG g635866.jpg GRAPHIC 27629
15 G194451.JPG g194451.jpg GRAPHIC 32637
16 G357412KEI001.JPG g357412kei001.jpg GRAPHIC 2562
  Complete submission text file 0001047469-10-001033.txt   1958504
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 10620510
SIC: 2834 Pharmaceutical Preparations